Global NewsNews

WHO launches global network to detect, prevent infectious disease threats

The International Pathogen Surveillance Network (IPSN) will provide a platform to connect countries and regions

WHO and partners are launching a global network to help protect people from infectious disease threats through the power of pathogen genomics. The International Pathogen Surveillance Network (IPSN) will provide a platform to connect countries and regions, improving systems for collecting and analysing samples, using these data to drive public health decision-making, and sharing that information more broadly.

Pathogen genomics analyses the genetic code of viruses, bacteria and other disease-causing organisms to understand how infectious they are, how deadly they are, and how they spread. With this information, scientists and public health officials can identify and track diseases to prevent and respond to outbreaks as part of a broader disease surveillance system, and to develop treatments and vaccines.

The IPSN, with a Secretariat hosted by the WHO Hub for Pandemic and Epidemic Intelligence, brings together experts worldwide at the cutting edge of genomics and data analytics, from governments, philanthropic foundations, multilateral organisations, civil society, academia and the private sector. All share a common goal: to detect and respond to disease threats before they become epidemics and pandemics, and to optimize routine disease surveillance.

“The goal of this new network is ambitious, but it can also play a vital role in health security: to give every country access to pathogen genomic sequencing and analytics as part of its public health system,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “As was so clearly demonstrated to us during the COVID-19 pandemic, the world is stronger when it stands together to fight shared health threats.”

“Global collaboration in pathogen genomic surveillance has been critical as the world fights COVID-19 together,” said Dr Rajiv J Shah, President, The Rockefeller Foundation. “IPSN builds upon this experience by creating a strong platform for partners across sectors and borders to share knowledge, tools, and practices to ensure that pandemic prevention and response is innovative and robust in the future.”

“Argentina is deeply invested in building our country capacity in pathogen genomics and the capacity of other countries,” said Josefina Campos, Director of the National Genomics and Bioinformatics Center at ANLIS Malbrán, Argentina. “Diseases do not respect borders: a disease threat in one country is also a threat to others. We look forward to collaborating with IPSN members to achieve our common goal of preventing illness and saving lives.”

The IPSN will tackle these challenges through a global network, connecting geographies and disease-specific networks, to build a collaborative system to better detect, prevent and respond to disease threats. Members will work together in dedicated groups focusing on specific challenges, supported by funding through the IPSN to scale up ideas and projects in pathogen genomics. By connecting countries, regions, and wider stakeholders, the IPSN will help to increase critical capacity, amplify regional and country-level voices, and strengthen their priorities.

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
IndiaMedToday
Close
Close